Matches in Wikidata for { <http://www.wikidata.org/entity/Q64120388> ?p ?o ?g. }
- Q64120388 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q64120388 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64120388 description "scientific article published on 01 December 2018" @default.
- Q64120388 description "wetenschappelijk artikel" @default.
- Q64120388 description "наукова стаття, опублікована в грудні 2018" @default.
- Q64120388 name "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 name "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 type Item @default.
- Q64120388 label "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 label "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 prefLabel "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 prefLabel "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 P1433 Q64120388-45412DB2-D745-43C5-A189-FDB779EB6FDE @default.
- Q64120388 P1476 Q64120388-12369F42-B2E7-46EA-846F-1C129C354399 @default.
- Q64120388 P2093 Q64120388-49456D9E-1142-4CC0-A0B0-9A8058D4824D @default.
- Q64120388 P2093 Q64120388-6D9EAB9F-226C-4456-B8D8-AF8C904962AA @default.
- Q64120388 P2093 Q64120388-7564010E-DDBD-48CC-A1DB-BD8AE310E272 @default.
- Q64120388 P2093 Q64120388-7FC926E8-79C3-42F5-8F42-466955E2042A @default.
- Q64120388 P2093 Q64120388-8B015502-F6BA-42C0-AC8E-11FC74219184 @default.
- Q64120388 P2093 Q64120388-913D29D4-B3DC-4FB2-8527-A187BEA3D657 @default.
- Q64120388 P2093 Q64120388-A7D205AC-E369-49D5-97D2-736F30E51028 @default.
- Q64120388 P2093 Q64120388-F4FD404B-7253-4F9A-BCBB-3CF5D3B296D4 @default.
- Q64120388 P2860 Q64120388-0144E30F-49C8-451E-A5B9-C9EBE9012F71 @default.
- Q64120388 P2860 Q64120388-048932A6-F08C-4695-8465-E5D441059E0D @default.
- Q64120388 P2860 Q64120388-12A28B4E-BF3D-4060-AD3C-4C8D23521D26 @default.
- Q64120388 P2860 Q64120388-150A39D2-0B66-4D25-8081-BA1C5B8E5392 @default.
- Q64120388 P2860 Q64120388-1517DAA8-AF25-4872-BB05-42259C4CB944 @default.
- Q64120388 P2860 Q64120388-1FB052EB-B0C0-494C-827B-3A20498F5E70 @default.
- Q64120388 P2860 Q64120388-219E2F9C-D857-4552-895E-C8787D9383FD @default.
- Q64120388 P2860 Q64120388-34B68E0E-7579-4654-851B-5FF1FCDBC303 @default.
- Q64120388 P2860 Q64120388-59C6B267-65A6-468D-8822-EE4AF89949E2 @default.
- Q64120388 P2860 Q64120388-5DE0CF47-4D3F-4A13-974F-5AB269C32D62 @default.
- Q64120388 P2860 Q64120388-661FD8B7-D79E-481D-9C8C-D3A18AD82FE8 @default.
- Q64120388 P2860 Q64120388-66A9146A-3077-4C5C-8B3F-CBA3BA093EF0 @default.
- Q64120388 P2860 Q64120388-6916F230-69B6-4500-8326-3754B62FDC92 @default.
- Q64120388 P2860 Q64120388-6C1AA9F1-D5BB-47F5-8918-67AE6C2DB6E0 @default.
- Q64120388 P2860 Q64120388-6E1F4692-0798-4A7B-B57C-9BE40200829F @default.
- Q64120388 P2860 Q64120388-71AD9506-7D2F-46D1-9F5F-43343306208C @default.
- Q64120388 P2860 Q64120388-7B1822F8-E32C-4584-8259-453C16C78D51 @default.
- Q64120388 P2860 Q64120388-9A433FA2-2972-4372-9685-4E0DA6DE3A02 @default.
- Q64120388 P2860 Q64120388-9DC5439B-C3B7-4FA4-88ED-13F0598303D2 @default.
- Q64120388 P2860 Q64120388-AF4F318A-14B6-440A-B516-6132E956DC3E @default.
- Q64120388 P2860 Q64120388-B37C9C1E-7E69-4525-9279-0F32EFA4DDFC @default.
- Q64120388 P2860 Q64120388-C136DD29-1B4A-4985-B52E-F237BACA2B80 @default.
- Q64120388 P2860 Q64120388-C550FFD2-11C6-494F-9217-D04E564C4C8E @default.
- Q64120388 P2860 Q64120388-D632FE52-9B95-48BE-8DB2-CC102170A14E @default.
- Q64120388 P2860 Q64120388-E39989E2-EBC8-4274-8AA1-F3EDDDAAF3F8 @default.
- Q64120388 P2860 Q64120388-E97832B4-9DD5-484B-8457-C7648D6DED64 @default.
- Q64120388 P2860 Q64120388-F0E7FF35-546B-430A-A93A-BCB3CF735AB9 @default.
- Q64120388 P2860 Q64120388-FDE88623-875E-427C-9932-A62CD80DCB73 @default.
- Q64120388 P304 Q64120388-9757DC2A-D2A8-4E96-9B1D-142E49ED00FF @default.
- Q64120388 P31 Q64120388-66FDCFAE-E828-42E4-9F51-E3BCDA4A7E50 @default.
- Q64120388 P356 Q64120388-00EAF0F7-444C-430F-876E-743283A92548 @default.
- Q64120388 P407 Q64120388-DE757E62-87E6-4346-B9EC-56BD79D92989 @default.
- Q64120388 P433 Q64120388-1B43B050-EDA1-4C44-A2F3-1D9AE5F24ED2 @default.
- Q64120388 P478 Q64120388-3DED5144-21FA-40C0-BF71-0ED6A1A7BBE7 @default.
- Q64120388 P50 Q64120388-18A09A14-7578-416F-A8D0-9FC5F6A894B7 @default.
- Q64120388 P50 Q64120388-20D89A44-6864-4376-B42F-F778DE97B95F @default.
- Q64120388 P50 Q64120388-25E2CDF0-CAD4-4476-BB1E-47EEEAAA6854 @default.
- Q64120388 P50 Q64120388-2B78B5AE-1AA8-4C42-A1FB-9A3AA20E37E4 @default.
- Q64120388 P50 Q64120388-36EB5415-243A-4A9A-ACE1-E04BF70DAC20 @default.
- Q64120388 P50 Q64120388-37124BF5-E3DC-498A-B3E6-00A5CA29E6C7 @default.
- Q64120388 P50 Q64120388-50639194-1FF5-4699-A3AB-6FBC9E5E073C @default.
- Q64120388 P50 Q64120388-6B7BED49-9F9C-43C3-AE72-15E19AE03311 @default.
- Q64120388 P50 Q64120388-6F431BA7-A645-4DFA-B88B-32B2EE1759CF @default.
- Q64120388 P50 Q64120388-7AC676D4-236C-4ED6-A746-7F0DAAE92D59 @default.
- Q64120388 P50 Q64120388-84DAEE41-EE3E-4656-B373-917449E58270 @default.
- Q64120388 P50 Q64120388-A12C7BEF-3DD8-4BA1-A5BF-5034689AACBE @default.
- Q64120388 P50 Q64120388-A482369D-D8D5-4F55-8EC6-DFA6B5DBFD38 @default.
- Q64120388 P50 Q64120388-EE141F53-D56D-45D2-AD56-B9321DD586B7 @default.
- Q64120388 P50 Q64120388-F5AA8B42-6482-465B-B8BB-47FA62E59C90 @default.
- Q64120388 P577 Q64120388-DA765E1A-B5BF-4D86-B554-0A4D629E00EB @default.
- Q64120388 P698 Q64120388-284B06DF-DCA1-45C8-A38C-60E47645939F @default.
- Q64120388 P921 Q64120388-149AE502-769D-4B85-9423-52B0C91C1B8F @default.
- Q64120388 P921 Q64120388-7DBEF70C-3821-4704-80CE-BB30941A63B5 @default.
- Q64120388 P921 Q64120388-A1215188-8F86-442B-909C-073BB8BCBE6B @default.
- Q64120388 P921 Q64120388-F11B59DB-0CB4-4A78-BC6D-ED95DF463900 @default.
- Q64120388 P921 Q64120388-F52413FE-D77C-4B76-804C-58F84FEB81D7 @default.
- Q64120388 P932 Q64120388-F46A1D9B-E2A0-4A81-8E47-5C16FEE3102E @default.
- Q64120388 P356 S2352-3026(18)30177-7 @default.
- Q64120388 P698 30501868 @default.
- Q64120388 P1433 Q26840042 @default.
- Q64120388 P1476 "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study" @default.
- Q64120388 P2093 "Andrea Lucas" @default.
- Q64120388 P2093 "Ariela Noy" @default.
- Q64120388 P2093 "John W Hayslip" @default.
- Q64120388 P2093 "Paolo Fabrizio Caimi" @default.
- Q64120388 P2093 "Rakesh Gaur" @default.
- Q64120388 P2093 "Richard F Little" @default.
- Q64120388 P2093 "Samir Parekh" @default.
- Q64120388 P2093 "Sunil Nagpal" @default.
- Q64120388 P2860 Q24646379 @default.
- Q64120388 P2860 Q27824784 @default.
- Q64120388 P2860 Q27860529 @default.
- Q64120388 P2860 Q30275206 @default.
- Q64120388 P2860 Q33407265 @default.
- Q64120388 P2860 Q33440896 @default.
- Q64120388 P2860 Q34526281 @default.
- Q64120388 P2860 Q35930640 @default.
- Q64120388 P2860 Q36364130 @default.